The present disclosure relates to implantable, mechanically expandable prosthetic devices, such as prosthetic heart valves, and to methods and delivery assemblies for such prosthetic devices.
The human heart can suffer from various valvular diseases. These valvular diseases can result in significant malfunctioning of the heart and ultimately require replacement of the native valve with an artificial valve. There are a number of known artificial valves and a number of known methods of implanting these artificial valves in humans.
Various surgical techniques may be used to replace or repair a diseased or damaged valve. Due to stenosis and other heart valve diseases, thousands of patients undergo surgery each year wherein the defective native heart valve is replaced by a prosthetic valve. Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves. The problem with surgical therapy is the significant risk it imposes on chronically ill patients, with high morbidity and mortality rates associated with surgical repair.
When the native valve is replaced, surgical implantation of the prosthetic valve typically requires an open-chest surgery during which the heart is stopped and patient placed on cardiopulmonary bypass (a so-called “heart-lung machine”). In one common surgical procedure, the diseased native valve leaflets are excised and a prosthetic valve is sutured to the surrounding tissue at the valve annulus. Because of the trauma associated with the procedure and the attendant duration of extracorporeal blood circulation, some patients do not survive the surgical procedure or die shortly thereafter. It is well known that the risk to the patient increases with the amount of time required on extracorporeal circulation. Due to these risks, a substantial number of patients with defective native valves are deemed inoperable because their condition is too frail to withstand the procedure. By some estimates, more than 50% of the subjects suffering from heart valve disease such as valve stenosis, valve insufficiency, etc., who are older than 80 years cannot be operated on for valve replacement.
Because of the drawbacks associated with conventional open-heart surgery, percutaneous and minimally-invasive surgical approaches are garnering attention. In one technique, a prosthetic valve is configured to be implanted in a much less invasive procedure by way of catheterization. For instance, U.S. Pat. Nos. 5,411,522 and 6,730,118, which are incorporated herein by reference, describe collapsible transcatheter heart valves that can be percutaneously introduced in a compressed state on a catheter and expanded in the desired position by balloon inflation or by utilization of a self-expanding frame or stent.
An important design consideration is the ability of the prosthetic heart valve to remain at the treatment location after deployment without becoming dislodged. In particular, there is a need for improvements to devices and methods for engaging the leaflets of a native heart valve when implanting a prosthetic heart valve.
Certain embodiments of the disclosure concern frames for prosthetic heart valves including leaflet clamps. In a representative embodiment, a frame for a prosthetic heart valve comprises a plurality of strut members arranged to form an annular main body of the frame and coupled together by a plurality of pivot joints. The main body of the frame is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration, and the main body of the frame has an inflow end and an outflow end. The frame further comprises a plurality of leaflet clamps disposed on an exterior of the main body of the frame and coupled to the strut members. The plurality of leaflet clamps are movable between an open position corresponding to the collapsed configuration of the main body of the frame and a closed position corresponding to the expanded configuration of the main body of the frame. Motion of the main body of the frame between the collapsed configuration and the expanded configuration causes corresponding motion of the leaflet clamps between the open position and the closed position.
In some embodiments, the leaflet clamps comprise a first end portion coupled to the main body of the frame and a free second end portion, and when the leaflet clamps are in the open position, the free second end portions are spaced radially outwardly from the main body of the frame.
In some embodiments, when the leaflet clamps are in the closed position, the free second end portions are disposed adjacent the main body of the frame.
In some embodiments, the strut members have respective inflow end portions located at the inflow end of the main body of the frame, respective outflow end portions located at the outflow end of the main body of the frame, and respective central portions between the inflow end portions and the outflow end portions. When the frame is in the expanded configuration, the central portions of the strut members are offset radially inwardly from the inflow end portions and from the outflow end portions of the strut members relative to a longitudinal axis of the frame such that the main body of the frame has an hourglass-shaped profile.
In some embodiments, when the frame is in the collapsed configuration, the central portions of the strut members are offset radially outwardly from the respective inflow end portions and outflow end portions of the strut members with respect to the longitudinal axis of the frame such that the main body of the frame has a barrel-shaped profile.
In some embodiments, the leaflet clamps each comprise a pair of strut members pivotably coupled to the strut members of the main body of the frame.
In some embodiments, the strut members of the leaflet clamps each comprise a first end portion and a second end portion, and when the leaflet clamps are in the open position, the second end portions of the strut members of the leaflet clamps are spaced radially outwardly from the main body of the frame.
In some embodiments, the second end portions of the strut members of each leaflet clamp are coupled to each other such that the leaflet clamps are V-shaped when the frame is in the expanded configuration.
In some embodiments, the first end portions of the strut members of the leaflet clamps are coupled to apices of the outflow end of the main body of the frame.
In some embodiments, a prosthetic heart valve comprises any of the frame embodiments described herein and a leaflet structure disposed at least partially within the frame.
In another representative embodiment, a frame for a prosthetic heart valve comprises a plurality of strut members arranged to form an annular main body. The main body of the frame is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration, has an inflow end and an outflow end, and defines a longitudinal axis. The strut members of the frame have respective inflow end portions located at the inflow end of the main body, respective outflow end portions located at the outflow end of the main body, and respective central portions between the inflow end portions and the outflow end portions. When the frame is in the expanded configuration, the central portions of the strut members are offset radially inwardly from the inflow end portions and from the outflow end portions of the strut members relative to the longitudinal axis such that the main body of the frame has an hourglass-shaped profile.
In some embodiments, when the main body of the frame is in the collapsed configuration, the central portions of the strut members are offset radially outwardly from the respective inflow end portions and outflow end portions of the strut members with respect to the longitudinal axis of the frame such that the main body of the frame has a barrel-shaped profile.
In some embodiments, the frame further comprises a plurality of leaflet clamps disposed on the exterior of the main body of the frame and coupled to the strut members.
In some embodiments, the leaflet clamps are movable between an open position corresponding to the collapsed configuration of the main body of the frame and a closed position corresponding to the expanded configuration of the main body of the frame.
In some embodiments, the leaflet clamps each comprise a pair of strut members pivotably coupled to the strut members of the main body of the frame.
In some embodiments, the strut members of the leaflet clamps each comprise a first end portion and a second end portion, and when the leaflet clamps are in the open position, the second end portions of the strut members of the leaflet clamps are spaced radially outwardly from the main body of the frame.
In some embodiments, the second end portions of the strut members of each leaflet clamp are coupled to each other such that the leaflet clamps are V-shaped when the frame is in the expanded configuration.
In some embodiments, the leaflet clamps are bowed when the frame is in the expanded configuration.
In some embodiments, the strut members of the main body of the frame are coupled together by a plurality of pivot joints.
In another representative embodiment, a method of implanting a prosthetic heart valve comprises advancing a prosthetic heart valve in a collapsed configuration to a native heart valve using a delivery apparatus. The prosthetic heart valve comprises a plurality of strut members coupled together by a plurality of pivot joints and arranged to form a frame having an annular main body. The main body of the frame is radially collapsible to the collapsed configuration and radially expandable to an expanded configuration, and includes a plurality of leaflet clamps disposed on the exterior of the main body of the frame and coupled to the strut members. The leaflet clamps are movable between an open position corresponding to the collapsed configuration of the main body of the frame and a closed position corresponding to the expanded configuration of the main body of the frame. The method further comprises positioning the prosthetic heart valve such that leaflets of the native heart valve are located between respective leaflet clamps and the main body of the frame, and radially expanding the prosthetic heart valve from the collapsed configuration to the expanded configuration such that the leaflet clamps move from the open position to the closed position and clamp the leaflets against the prosthetic heart valve.
In some embodiments, the leaflet clamps comprise first end portions coupled to an outflow end of the main body of the frame and free second end portions, and radially expanding the prosthetic heart valve further comprises expanding the main body of the frame beyond a natural diameter of the strut members such that the outflow end of the main body of the frame moves radially outwardly of a central portion of the main body of the frame and the free second end portions of the leaflet clamps move adjacent the main body of the frame.
The foregoing and other objects, features, and advantages of the disclosed technology will become more apparent from the following detailed description, which proceeds with reference to the accompanying figures.
The present disclosure concerns embodiments of implantable prosthetic devices and, in particular, implantable prosthetic valves, and methods for implanting such devices. In particular embodiments, the prosthetic device comprises a prosthetic heart valve, and can be configured to be implanted in any of the native heart valves (aortic, mitral, pulmonary, and tricuspid). In addition, the prosthetic heart valve can be, for example, a transcatheter heart valve, a surgical heart valve, or a minimally-invasive heart valve. The prosthetic valve also can comprise other types of valves implantable within other body lumens outside of the heart, or heart valves that are implantable within the heart at locations other than the native valves, such as trans-atrial or trans-ventricle septum valves.
The disclosed prosthetic heart valves are particularly suited for implantation in the native aortic valve. In the context of a prosthetic aortic valve, the terms “lower” and “upper” are used interchangeably with the terms “inflow” and “outflow”, respectively, for convenience. Thus, for example, the lower end of the prosthetic valve is its inflow end and the upper end of the prosthetic valve is its outflow end in the orientation shown in the drawings. However, it should be understood that the prosthetic valve can be implanted in the reverse orientation. For example, for implantation at the mitral valve position, the upper end of the prosthetic valve is the inflow end and the lower end of the valve is the outflow end.
In some embodiments, the prosthetic valves described herein can include docking mechanisms configured as leaflet clamps to clamp the leaflets of a native heart valve against the prosthetic heart valve. In certain configurations, the leaflet clamps can be movable between an open configuration corresponding to a radially collapsed configuration of the prosthetic valve, and a closed configuration corresponding to a radially expanded configuration of the prosthetic valve. In some embodiments, the diameter of the frame of the prosthetic valve can vary along a longitudinal axis of the frame. The diameter of various parts of the frame can also vary between the collapsed configuration and the expanded configuration. For example, in certain configurations, the inflow and outflow ends of the frame can be disposed radially inwardly of the central portion of the frame when the frame is in the collapsed configuration such that the frame has a convex or barrel-shaped profile. Conversely, when the frame is in the expanded configuration, the central portion of the frame can be disposed radially inwardly of the inflow and outflow ends of the frame such that the frame exhibits a concave or hourglass-shaped outer profile. When the leaflet clamps are coupled to the frame, this radial motion of the inflow and outflow ends of the frame relative to the central portion of the frame can be used to actuate the leaflet clamps between an open position, in which a leaflet-receiving space is defined between the leaflet clamps and the frame, and a closed position, in which the leaflet clamps are disposed against or adjacent the frame.
For example,
The frame 12 can include a plurality of interconnected strut members 22 (also referred to as “first strut members”) arranged in a lattice-type pattern and forming a plurality of apices 24 at the inflow and outflow ends 16, 18 of the main body 13 of the prosthetic valve. In the illustrated configuration, the frame 12 includes a first set of strut members 22A and a second set of strut members 22B. The strut members 22A of the first set are located radially inward of the strut members 22B of the second set such that the strut members 22B are on the outside of the frame. In the illustrated example, the strut members 22A can be angled in a first direction, and can extend helically about a longitudinal axis 78 of the frame 12, while the strut members 22B can be angled in the opposite direction to the strut members 22A, and can extend helically about the longitudinal axis 78 in a direction opposite to the helicity of the strut members 22A.
As shown in
Each linear segment 38 can be slightly laterally offset from an adjacent linear segment 38 in a direction perpendicular to the overall length of the strut 22 to provide the zig-zag pattern to the strut. Each of the intermediate segments 40 and end portions 41 and 42 can have a respective opening 28 at its geometric center for receiving a fastener 30 (
The linear segments 38 can include at least substantially flat or linear opposing longitudinal edges 46a, 46b extending between curved or rounded edges 48 of the intermediate segments 40. In alternative embodiments, the opposing edges 48 of the intermediate segments 40 can be substantially flat or linear edges that extend at an angle between respective ends of the edges 46a, 46b of the liner segments 38.
As best shown in
In alternative embodiments, the width W1 of each linear segment 38 can vary along the length of a strut. For example, the width W1 of a linear segment 38 adjacent the inflow end of the frame can be greater than the width W1 of a linear segment 38 adjacent the outflow end of the frame, or vice versa. Further, where the widths W1 of the linear segments 38 vary along the length of a strut 22, a linear segment can have one longitudinal edge 46a or 46b that is collinear with a longitudinal edge of an adjacent linear segment on the same side of the strut, while the other longitudinal edge 46a, 46b is laterally offset from the longitudinal edge of an adjacent linear strut on the same side of the strut. In other words, the strut 22 can have an overall zig-zag or offset pattern by virtue of the varying widths W1 of the linear segments.
In alternative embodiments, the struts 22 can have linear segments 38 that are not offset from each other; that is, the struts are substantially rectangular with longitudinal sides of each strut extending continuously from one end of the strut to the opposite end of the strut without offset portions (e.g., similar to struts 68, described below)
Returning to
The joints 26 can allow the strut members 22A to pivot relative to the strut members 22B as the frame 12 is expanded or contracted, such as during assembly, preparation, or implantation of the prosthetic valve 10. For example, the frame 12 (and thus the prosthetic valve 10) can be manipulated into a radially compressed or contracted configuration (see
The frame 12 can be configured to protect the soft components (e.g., the leaflets 20, and any skirts, sutures, etc., that form part of the prosthetic valve) from being pinched or cut by the frame during crimping and expansion of the prosthetic valve. For example,
Returning to
In the illustrated configuration, the inner members 56 can have distal end portions 60 coupled to the inflow end 16 of the frame 12 (e.g., with a coupling element such as a pin member). In the illustrated embodiment, each of the inner members 56 is coupled to the frame at respective apices 24 at the inflow end 16 of the frame. The outer members 58 can be coupled to apices 24 at the outflow end 18 of the frame 12 at, for example, a mid-portion of the outer member, as shown in
The inner member 56 and the outer member 58 can telescope relative to each other between a fully contracted state (corresponding to a fully radially expanded state of the prosthetic valve) and a fully extended state (corresponding to a fully radially compressed state of the prosthetic valve). In the fully extended state, the inner member 56 is fully extended from the outer member 58. In this manner, the actuator components 54 allow the prosthetic valve to be fully expanded or partially expanded to different diameters inside a patient's body and retain the prosthetic valve in the partially or fully expanded state. The inner and outer members 56, 58 have respective locking elements that are configured to engage each other and prevent radial compression of the frame when the frame is expanded to a desired expanded diameter and the locking elements are actuated by a user, as further disclosed in U.S. Publication No. 2018/0153689.
The prosthetic valve 10 can include various other types of actuators and/or locking devices for controlling radial expansion of the valve and/or retaining the valve in an expanded state. In some embodiments, for example, the actuator components 54 can be screw actuators configured to radially expand and collapse the frame 12 by rotation of one of the components of the actuators. For example, the inner members 56 can be configured as screws having external threads that engage internal threads of corresponding outer components. In some embodiments, the internal friction or resistance of the screws within the screw actuators can be sufficient to retain the frame in a desired expanded state. Further details regarding screw actuators and various other types of actuators and locking devices that can be incorporated in the prosthetic valve are disclosed in: U.S. Patent Publication No. 2018/0153689; U.S. Application Ser. No. 16/105,353, filed Aug. 20, 2018; and U.S. Publication No. 2014/0296962, all of which documents are incorporated herein by reference.
Still referring to
Referring to
In the illustrated embodiment, the prosthetic valve 10 includes three clamps 66, although a greater or fewer number may be used. The clamps 66 are desirably, although not necessarily, equally angularly spaced around the circumference of the main body of the frame. When intended to be implanted within a native valve having three leaflets (e.g., the aortic valve), the prosthetic valve 10 can have three clamps 66, with each clamp being positioned to clamp onto one of the native leaflets. When intended to be implanted within a native valve having two leaflets (e.g., the mitral valve), the prosthetic valve 10 can have two clamps 66, with each clamp being positioned to clamp onto one of the native leaflets. In other embodiments, the prosthetic valve 10 can have a number of clamps 66 that does not equal the number of native leaflets of the native valve in which the prosthetic valve 10 is to be implanted and/or the prosthetic valve 10 can have more than one clamp that is positioned to clamp onto a single native leaflet.
In the illustrated embodiment, each leaflet clamp 66 can comprise a pair of strut members 68 (also referred to as “second strut members”). The strut members 68 can include respective first end portions 70, central portions 72, and second end portions 74. The first end portions 70 can be coupled to the main body 13 of the frame 12. More particularly, in certain embodiments, the first end portions 70 of the strut members 68 can be pivotably coupled to adjacent apices 24 (e.g., with the pivot joints 26) at the outflow end 18 of the frame. The second end portions 74 of the strut members 68 of each clamp 66 can be pivotably coupled to each other by a pivot joint 94. In this manner, the leaflet clamps 66 can be movable between an expanded configuration (
For example, when the prosthetic valve 10 is in the expanded configuration, the leaflet clamps 66 are also in the expanded configuration, and the first end portions 70 of the strut members 68 are circumferentially spaced apart from each other around the frame 12 such that the strut members 68 form a V-shape. In the illustrated embodiment, the opening of the V is oriented toward the outflow end of the frame. When the prosthetic valve 10 is moved to the collapsed configuration, the leaflet clamps 66 can move to the collapsed configuration as well. For example, the first end portions 70 of the strut members 68 can pivot about the pivot joints 26 such that the first end portions 70 move closer together as the frame 12 is radially collapsed to the configuration shown in
In certain embodiments, the main body 13 of the frame 12 can be configured such that it has a barrel-shaped profile when in the collapsed configuration, and an hourglass-shaped profile when in the expanded configuration. As used herein, the term “barrel-shaped profile” means that a central portion 80 of the main body 13 of the frame 12 is offset radially outwardly from the inflow end 16 and the outflow end 18 with respect to a longitudinal axis 78 of the main body of the frame 12 such that a diameter of the central portion of the main body is greater than the diameters of the inflow and outflow ends of the main body. As used herein, the term “hourglass-shaped profile” means that the central portion 80 of the main body 13 is offset radially inwardly from the inflow end 16 and from the outflow end 18 of the frame relative to the longitudinal axis 78 such that the diameter of the central portion of the main body is less than the diameters of the inflow and outflow ends of the main body.
For example,
When the prosthetic valve 10 is crimped to the radially collapsed configuration, which is less than the natural diameter D1 of the main body of the frame, the central portions 76 of the strut members 22 can tend to bow radially outwardly such that the main body 13 of the frame 12 has a barrel-shaped profile, as shown in
Conversely, when the prosthetic valve 10 is expanded to the expanded configuration, the main body 13 can be expanded beyond its natural diameter D1 such that the frame has an hourglass-shaped profile, as shown in
The fully assembled frame 12 including both the inner and outer sets of strut members 22A and 22B can exhibit the shapes described above when in the collapsed and expanded configurations, although the degree of the barrel-shaped profile and the hourglass-shaped profile achieved can vary due to constraints imposed by the joints 26 and the opposite helicity of the inner and outer sets of strut members 22A and 22B. In one representative example, the natural diameter D1 of the main body of the frame can be from 13 mm to 16 mm. Thus, when the frame is crimped to the collapsed configuration, the diameter D3 of the central portion 80 of the main body 13 can be 6 mm. When expanded to the functional size, the main body 13 can be expanded beyond its natural diameter to achieve the hourglass shape. In the above example, the diameter D6 of the central portion 80 of the main body 13 can be 24 mm to 26 mm at its functional size. As shown in
The variation in the radial position of the inflow and outflow ends 16, 18 of the main body of the frame 12 with respect to the central portion 80 can be utilized to move or actuate the leaflet clamps 66 between the open and closed positions. For example,
Conversely, when the prosthetic valve 10 is expanded to its functional size, the main body 13 of the frame 12 can assume the hourglass-shaped profile illustrated in
As shown in
The strut members 22 and/or the strut members 68 can be made from any of various biocompatible materials. For example, in certain embodiments, the strut members 22 and/or the strut members 68 can be made from any of various metal alloys, including nickel titanium alloys such as nitinol, or stainless steel, etc.
The disclosed prosthetic valve embodiments can be radially collapsed and delivered to the heart percutaneously using any of a variety of delivery systems. For example,
The delivery assembly 100 can include second actuation members (not shown) that extend co-axially through the first actuation members and are connected to respective inner members 56. To produce radial expansion of the prosthetic valve, the first actuation members 106 are actuated to apply a distally directed force to the frame 12 and/or the second actuation members are actuated to apply a proximally directed force to the inner members 56. To produce radial compression of the prosthetic valve, the first actuation members 106 are actuated to apply a proximally directed force to the frame 12 and/or the second actuation members are actuated to apply a distally directed force to the inner members 56.
Initially, the prosthetic valve 10 can be in a radially collapsed configuration within a sheath 110 of the shaft 104. The sheath 110 retains the clamps 66 against the outer surface of the frame 12 during delivery of the prosthetic valve. When the distal end of the delivery apparatus has been advanced through the patient's vasculature to the treatment site (e.g., at the ascending aorta), the prosthetic valve 10 can be advanced from the sheath 110, such as by using a rotatable actuator 112 on the handle 102. The clamps desirably have sufficient elasticity such that when the prosthetic valve is deployed from the sheath, the clamps 66 can automatically self-expand away from the frame 12 to their open positions shown in
In alternative embodiments, the leaflet clamps 66 can comprise a single member instead of two strut members 68 coupled together. For example, in certain embodiments, the leaflet clamps 66 can comprise a single strut member that is curved such that it is U-shaped or V-shaped similar to the leaflet clamps 66. Such a strut member can be made from, for example, any of various shape-memory alloys such that the strut member can be crimped, and can spring back to its functional shape upon expansion of the frame. In yet further configurations, the leaflet clamps 66 can comprise a single straight strut member similar to the strut members 68 that is configured to move between the open position and the closed position together with the frame 12. In certain embodiments, the leaflet clamps 66 can also include any of a variety of atraumatic coverings, such as woven or non-woven fabric, any of various electrospun coatings, etc., such as described below with reference to
The leaflet clamp embodiments described herein can provide significant advantages over known prosthetic valve docking mechanisms. For example, because the leaflet clamps are part of the frame, a separate docking member and the associated delivery apparatus are not required. Additionally, because the leaflet clamps are actuated between the open and closed positions by motion of the frame between the contracted and expanded configurations, the leaflet clamps can be easily reopened and the prosthetic valve repositioned until the surgeon is satisfied with the placement of the prosthetic valve. An associated advantage of the mechanically expandable frame is that a balloon is not required to expand the frame to its functional size and, thus, there is no occlusion of blood flow during valve expansion. Also, because the leaflet clamps are actuated by motion of the prosthetic valve rather than by being self-expanding, the leaflet clamps need not be made from super-elastic or shape memory materials. Instead, the strut members forming the clamps can be made from relatively stronger and/or stiffer materials, such as stainless steel or cobalt-chromium alloys. In use, the strut members of the clamps are deformed within their elastic range when the frame is radially expanded and collapsed to move the clamps between their open and closed positions.
Additionally, although the illustrated configuration is adapted for implantation in the aortic valve, the frame and leaflet clamps can also be configured for implantation in the mitral valve and/or the tricuspid valve. For example, by reversing the orientation of the leaflet clamps 66 such that the first end portions 70 of the strut members 68 are coupled to the apices 24 at the lower end 16 of the frame (e.g., the outflow end of the frame when implanted at the mitral valve position), the leaflet clamps can be configured for use with the mitral valve and/or the tricuspid valve.
Explanation of Terms
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.
As used in this application and in the claims, the singular forms “a,” “an,” and “the” include the plural forms unless the context clearly dictates otherwise. Additionally, the term “includes” means “comprises.” Further, the terms “coupled” and “associated” generally mean electrically, electromagnetically, and/or physically (e.g., mechanically or chemically) coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.
In the context of the present application, the terms “lower” and “upper” are used interchangeably with the terms “inflow” and “outflow”, respectively. Thus, for example, the lower end of the valve is its inflow end and the upper end of the valve is its outflow end.
As used herein, the term “proximal” refers to a position, direction, or portion of a device that is closer to the user and further away from the implantation site. As used herein, the term “distal” refers to a position, direction, or portion of a device that is further away from the user and closer to the implantation site. Thus, for example, proximal motion of a device is motion of the device toward the user, while distal motion of the device is motion of the device away from the user. The terms “longitudinal” and “axial” refer to an axis extending in the proximal and distal directions, unless otherwise expressly defined.
Unless otherwise indicated, all numbers expressing dimensions, quantities of components, angles, molecular weights, percentages, temperatures, forces, times, and so forth, as used in the specification or claims, are to be understood as being modified by the term “about.” Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that can depend on the desired properties sought and/or limits of detection under test conditions/methods familiar to those of ordinary skill in the art. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word “about” is recited. Furthermore, not all alternatives recited herein are equivalents.
In view of the many possible embodiments to which the principles of the disclosed technology may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure. Rather, the scope of the disclosure is at least as broad as the following claims. We therefore claim all that comes within the scope and spirit of these claims.
The present application claims the benefit of U.S. Provisional Application No. 62/663,615, filed on Apr. 27, 2018, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3409013 | Berry | Nov 1968 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
RE30912 | Hancock | Apr 1982 | E |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4820299 | Philippe et al. | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5558644 | Boyd et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5628792 | Lentell | May 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6338740 | Carpentier | Jan 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352547 | Brown et al. | Mar 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440764 | Focht et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6527979 | Constantz et al. | Mar 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6689123 | Pinchasik | Feb 2004 | B2 |
6716244 | Klaco | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6769161 | Brown et al. | Aug 2004 | B2 |
6783542 | Eidenschink | Aug 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6878162 | Bales et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7096554 | Austin et al. | Aug 2006 | B2 |
7225518 | Eidenschink et al. | Jun 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7316710 | Cheng et al. | Jan 2008 | B1 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7563280 | Anderson et al. | Jul 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7655034 | Mitchell et al. | Feb 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7959665 | Pienknagura | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8075611 | Millwee et al. | Dec 2011 | B2 |
8128686 | Paul, Jr. et al. | Mar 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8291570 | Eidenschink et al. | Oct 2012 | B2 |
8348998 | Pintor et al. | Jan 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8747463 | Fogarty et al. | Jun 2014 | B2 |
9078781 | Ryan et al. | Jul 2015 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020026094 | Roth | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020138135 | Duerig et al. | Sep 2002 | A1 |
20020143390 | Ishii | Oct 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20030014105 | Cao | Jan 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040024452 | Kruse et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040078074 | Anderson et al. | Apr 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075728 | Nguyen et al. | Apr 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050188525 | Weber et al. | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060108090 | Ederer et al. | May 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060183383 | Asmus et al. | Aug 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070203576 | Lee et al. | Aug 2007 | A1 |
20070208550 | Cao et al. | Sep 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070260305 | Drews et al. | Nov 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080183271 | Frawley et al. | Jul 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080275537 | Limon | Nov 2008 | A1 |
20080294248 | Yang et al. | Nov 2008 | A1 |
20090118826 | Khaghani | May 2009 | A1 |
20090125118 | Gong | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090299452 | Eidenschink et al. | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100049313 | Mon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100168844 | Toomes et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100198347 | Zakay et al. | Aug 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110066224 | White | Mar 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110319991 | Hariton et al. | Dec 2011 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120259409 | Nguyen et al. | Oct 2012 | A1 |
20130023985 | Khairkhahan et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130190857 | Mitra et al. | Jul 2013 | A1 |
20130274873 | Delaloye et al. | Oct 2013 | A1 |
20130310926 | Hariton | Nov 2013 | A1 |
20130317598 | Rowe et al. | Nov 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140200661 | Pintor et al. | Jul 2014 | A1 |
20140209238 | Bonyuet et al. | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140277417 | Schraut et al. | Sep 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140277424 | Oslund | Sep 2014 | A1 |
20140277563 | White | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140343671 | Yohanan et al. | Nov 2014 | A1 |
20140350667 | Braido et al. | Nov 2014 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150073546 | Braido | Mar 2015 | A1 |
20150135506 | White | May 2015 | A1 |
20150157455 | Hoang et al. | Jun 2015 | A1 |
20170014229 | Nguyen-Thien-Nhon et al. | Jan 2017 | A1 |
20180028310 | Gurovich et al. | Feb 2018 | A1 |
20180153689 | Maimon et al. | Jun 2018 | A1 |
20180325665 | Gurovich et al. | Nov 2018 | A1 |
20180344456 | Barash et al. | Dec 2018 | A1 |
20190038405 | Iamberger | Feb 2019 | A1 |
Number | Date | Country |
---|---|---|
2246526 | Mar 1973 | DE |
0144167 | Jun 1985 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
0103546 | Mar 1984 | EP |
0850607 | Jul 1998 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1570809 | Sep 2005 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2056023 | Mar 1981 | GB |
1271508 | Nov 1986 | SU |
9117720 | Nov 1991 | WO |
9217118 | Oct 1992 | WO |
9301768 | Feb 1993 | WO |
9724080 | Jul 1997 | WO |
9829057 | Jul 1998 | WO |
9930646 | Jun 1999 | WO |
9933414 | Jul 1999 | WO |
0018333 | Apr 2000 | WO |
0047139 | Aug 2000 | WO |
0135878 | May 2001 | WO |
0149213 | Jul 2001 | WO |
0154624 | Aug 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0241789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0247575 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
2005034812 | Apr 2005 | WO |
2005055883 | Jun 2005 | WO |
2005084595 | Sep 2005 | WO |
2005102015 | Nov 2005 | WO |
2006014233 | Feb 2006 | WO |
2006032051 | Mar 2006 | WO |
2006034008 | Mar 2006 | WO |
2006111391 | Oct 2006 | WO |
2006127089 | Nov 2006 | WO |
2006138173 | Dec 2006 | WO |
2007047488 | Apr 2007 | WO |
2007067942 | Jun 2007 | WO |
2007097983 | Aug 2007 | WO |
2008005405 | Jan 2008 | WO |
2008015257 | Feb 2008 | WO |
2008029296 | Mar 2008 | WO |
2008035337 | Mar 2008 | WO |
2008091515 | Jul 2008 | WO |
2008147964 | Dec 2008 | WO |
2008150529 | Dec 2008 | WO |
2009033469 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009053497 | Apr 2009 | WO |
2009061389 | May 2009 | WO |
2009116041 | Sep 2009 | WO |
2009149462 | Dec 2009 | WO |
2010011699 | Jan 2010 | WO |
2010121076 | Oct 2010 | WO |
2013106585 | Jul 2013 | WO |
2015085218 | Jun 2015 | WO |
Entry |
---|
H.R. Andersen, et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992. |
H.R. Andersen “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992. |
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994. |
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989. |
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197. |
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989. |
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986. |
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986. |
Number | Date | Country | |
---|---|---|---|
20190328518 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
62663615 | Apr 2018 | US |